Track Docket
Download Docs
Export
Judge 
Party 
Law Firm Pfizer/Mylan, In the Matter of
C-4727 | Federal Trade Commission
Interested in this case?
Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed
Oct. 30, 2020
FTC Matter/File Number
191 0182
Case Summary
Pharmaceutical companies Pfizer Inc. and Mylan N.V. have agreed to divest assets and abide by other conditions to settle Federal Trade Commission charges that the proposed combination of Upjohn Inc. and Mylan N.V. will harm current or future competition in ten generic drug markets. The FTC’s complaint alleges that the proposed combination would harm current U.S. competition in seven product markets by reducing the number of existing suppliers, and that it would harm future U.S. competition in three additional product markets. The proposed consent order requires divestitures in all 10 markets.
Pharmaceutical companies Pfizer Inc. and Mylan N.V. have agreed to divest assets and abide by other conditions to settle Federal Trade Commission charges that the proposed combination of Upjohn Inc. and Mylan N.V. will harm current or future competition in ten generic drug markets. The FTC’s complaint alleges that the proposed combination would harm current U.S. competition in seven product markets by reducing the number of existing suppliers, and that it would harm future U.S. competition in three additional product markets. The proposed consent order requires divestitures in all 10 markets.
Case Type
Administrative
Last Updated: 2 years, 8 months ago
| Filing Date | # | Docket Text |
|---|
